Novo Nordisk A/S
Time frame: 1 December 2022 - 30 November 2023Article ‘Count’ and ‘Share’ for Novo Nordisk A/S based on listed parameters only.
The articles listed below published by authors from Novo Nordisk A/S, organized by journal and article, represent the research output in Count and Share according to the parameters selected above.
| Journal | Count | Share |
|---|---|---|
|
American Journal of Human Genetics |
1 | 0.05 |
|
Analytical Chemistry |
1 | 0.08 |
|
Angewandte Chemie International Edition |
1 | 0.13 |
|
Cell Metabolism |
2 | 0.71 |
|
Diabetes Care |
2 | 0.46 |
|
Human Reproduction |
1 | 0.80 |
|
International Journal of Epidemiology |
1 | 0.13 |
|
International Journal of Obesity |
2 | 0.95 |
|
JAMA: The Journal of the American Medical Association |
1 | 0.33 |
|
Journal of Clinical Endocrinology & Metabolism |
3 | 0.69 |
|
Journal of Clinical Investigation |
1 | 0.19 |
|
Journal of Hepatology |
1 | 0.14 |
|
Journal of the American Academy of Dermatology |
1 | 0.02 |
|
Journal of the American College of Cardiology |
1 | 0.25 |
|
Journal of the American Society of Nephrology |
1 | 0.06 |
|
Kidney International |
1 | 0.38 |
|
Nature |
2 | 0.08 |
|
Nature Cell Biology |
1 | 0.15 |
|
Nature Chemistry |
1 | 0.13 |
|
Nature Communications |
6 | 0.61 |
|
Nature Genetics |
1 | 0.01 |
|
Nature Medicine |
1 | 0.18 |
|
PLOS Medicine |
2 | 0.09 |
|
Proceedings of the National Academy of Sciences of the United States of America |
1 | 0.25 |
|
Science Translational Medicine |
2 | 0.06 |
|
The Lancet |
5 | 1.88 |
|
The Lancet Diabetes & Endocrinology |
3 | 0.79 |
|
The New England Journal of Medicine |
4 | 1.10 |
Numerical information only is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.